SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Usana Health Sciences Inc – ‘10QSB’ for 9/30/96 – EX-11

As of:  Thursday, 11/14/96   ·   For:  9/30/96   ·   Accession #:  1010924-96-70   ·   File #:  0-21116

Previous ‘10QSB’:  ‘10QSB’ on 8/12/96 for 6/30/96   ·   Latest ‘10QSB’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/14/96  Usana Health Sciences Inc         10QSB       9/30/96    3:26K                                    Durham Jones & P… P C/FA

Quarterly Report — Small Business   —   Form 10-QSB
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10QSB       Quarterly Report -- Small Business                    11±    52K 
 3: EX-11       Statement re: Computation of Earnings Per Share        1      7K 
 2: EX-27       Financial Data Schedule (Pre-XBRL)                     1      5K 


EX-11   —   Statement re: Computation of Earnings Per Share



USANA, INC. & SUBSIDIARY COMPUTATION OF EARNINGS PER COMMON AND COMMON EQUIVALENT SHARES Unaudited [Enlarge/Download Table] Three months ended Nine months ended --------------------------------- -------------------------------- September 30, September 30, September 30, September 30, 1996 1995 1996 1995 -------------- -------------- -------------- -------------- Average number of shares outstanding during period Common shares outstanding 6,326,619 5,315,742 6,280,119 5,315,742 during entire period Weighted average common 11,522 325,425 16,514 288,491 shares issued during the period Dilutive effect of common stock equivalents under stock options ---- ---- ---- ---- (based on the Treasury stock method)* -------------- -------------- -------------- -------------- Weighted average common and com- mon equivalent shares outstanding 6,338,141 5,641,167 6,296,633 5,604,233 ============== ============== ============== ============== Net earnings $ 1,457,338 $ 526,301 $ 4,045,503 $ 1,432,541 ============== ============== ============== ============== Earnings per common and common equivalent share $ 0.23 $ 0.09 $ 0.64 $ 0.26 ============== ============== ============== ============== * Not included in this earnings per share calculation, since the total dilutive effect of all common stock equivalents calculated under the treasury stock method is less than 3% for the three and nine months ended September 30, 1996 and 1995.

Dates Referenced Herein

This ‘10QSB’ Filing    Date    Other Filings
Filed on:11/14/96None on these Dates
For Period End:9/30/96
9/30/95
 List all Filings 
Top
Filing Submission 0001010924-96-000070   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 3:46:56.1am ET